Patent · US Active

Macrocycle kinase inhibitors

US10689400B2 · kind B2 · utility

5Cited by
8References
19Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJul 27, 2017
Grant dateJun 23, 2020
Priority date
Expiry dateJul 27, 2037

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P43/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present disclosure relates to certain macrocyclic kinase inhibitors, pharmaceutical compositions containing the same, and methods of using the same to treat disease.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.